Guideline for the laboratory diagnosis of functional iron deficiency
暂无分享,去创建一个
[1] D. Swinkels,et al. Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] J. Adamson,et al. Notice , 2012, Kidney International Supplements.
[3] D. Coyne. Hepcidin: clinical utility as a diagnostic tool and therapeutic target. , 2011, Kidney international.
[4] D. Henry. Parenteral iron therapy in cancer-associated anemia. , 2010, Hematology. American Society of Hematology. Education Program.
[5] T. Ganz,et al. Detection, evaluation, and management of iron-restricted erythropoiesis. , 2010, Blood.
[6] D. Girelli,et al. Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] A. Mangione,et al. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] I. Macdougall,et al. Current status of the measurement of blood hepcidin levels in chronic kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[9] M. Rebeschini,et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. , 2010, American journal of clinical pathology.
[10] A. Heath,et al. A WHO Reference Reagent for the Serum Transferrin Receptor (sTfR): international collaborative study to evaluate a recombinant soluble transferrin receptor preparation , 2010, Clinical chemistry and laboratory medicine.
[11] K. Nitta,et al. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency , 2010, International journal of laboratory hematology.
[12] E. Urrechaga. The new mature red cell parameter, low haemoglobin density of the Beckman‐Coulter LH750: clinical utility in the diagnosis of iron deficiency , 2010, International journal of laboratory hematology.
[13] E. Urrechaga. Clinical utility of the new beckman‐coulter parameter red blood cell size factor in the study of erithropoiesis , 2009, International journal of laboratory hematology.
[14] L. Borque,et al. Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism , 2009, Clinical chemistry and laboratory medicine.
[15] Anastasios Koulaouzidis,et al. Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. , 2009, Journal of gastrointestinal and liver diseases : JGLD.
[16] P. Danise,et al. Erythrocyte and reticulocyte indices in iron deficiency in chronic kidney disease: comparison of two methods , 2009, Scandinavian journal of clinical and laboratory investigation.
[17] D. Dietzen,et al. Reticulocyte hemoglobin content , 2008, American journal of hematology.
[18] Ajay K. Singh,et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. , 2007, Journal of the American Society of Nephrology : JASN.
[19] G. Zini,et al. Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy. , 2007, Laboratory hematology : official publication of the International Society for Laboratory Hematology.
[20] T. Ganz. Molecular control of iron transport. , 2007, Journal of the American Society of Nephrology : JASN.
[21] C. Brugnara,et al. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states , 2006, Clinical and laboratory haematology.
[22] D. Tarng,et al. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[23] Kdoqi. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] Kdoqi Disclaimer,et al. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] G. Lippi,et al. Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. , 2005, The Journal of laboratory and clinical medicine.
[26] J. Linssen,et al. Reticulocyte hemoglobin measurement – comparison of two methods in the diagnosis of iron-restricted erythropoiesis , 2005, Clinical chemistry and laboratory medicine.
[27] K. Kalantar-Zadeh,et al. Time-dependent associations between iron and mortality in hemodialysis patients. , 2005, Journal of the American Society of Nephrology : JASN.
[28] B. Möller,et al. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin , 2005, Annals of Hematology.
[29] Jerry Kaplan,et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.
[30] G. Aronoff,et al. Making sense: a scientific approach to intravenous iron therapy. , 2004, Journal of the American Society of Nephrology : JASN.
[31] B. Bain,et al. How should stainable iron in bone marrow films be assessed? , 2004, Journal of Clinical Pathology.
[32] F. Locatelli,et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] C. Brugnara,et al. Iron deficiency and erythropoiesis: new diagnostic approaches. , 2003, Clinical chemistry.
[34] D. Tarng,et al. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] T. Littlewood,et al. Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patients. , 2003, The oncologist.
[36] Yung-Ming Chen,et al. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients. , 2002, Clinical nephrology.
[37] Keith C. Norris,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] Eun Jung Lee,et al. Soluble transferrin receptor (sTfR), ferritin, and sTfR/log ferritin index in anemic patients with nonhematologic malignancy and chronic inflammation. , 2002, Clinical chemistry.
[39] Christian Thomas,et al. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. , 2002, Clinical chemistry.
[40] D. Dietzen,et al. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. , 2002, Blood.
[41] S. Fishbane,et al. A randomized trial of iron deficiency testing strategies in hemodialysis patients. , 2001, Kidney international.
[42] A. Lupo,et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[43] A. Tefferi,et al. A bone marrow report of absent stainable iron is not diagnostic of iron deficiency , 2001, Annals of Hematology.
[44] K. Abdulkadyrov,et al. HLA-DR4-Ala74β is associated with risk and poor outcome of severe aplastic anemia , 2001, Annals of Hematology.
[45] M. Hartmann,et al. Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome. , 1999, Southern medical journal.
[46] I. Cavill,et al. Iron status as measured by serum ferritin: the marker and its limitations. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[47] P. Saavedra-Santana,et al. Diagnosis of iron deficiency in chronic renal failure. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[48] S. Schuster,et al. Serum soluble transferrin receptor and the prediction of marrow aspirate iron results in a heterogeneous group of patients. , 1999, Clinical and laboratory haematology.
[49] R. Mushnick,et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[50] G. Bailie,et al. Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients. , 1997, Renal failure.
[51] M. Worwood. The laboratory assessment of iron status--an update. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[52] S. Fishbane,et al. Iron management in end-stage renal disease. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[53] K. Punnonen,et al. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. , 1997, Blood.
[54] E. Graham,et al. Elevated zinc protoporphyrin associated with thalassemia trait and hemoglobin E. , 1996, The Journal of pediatrics.
[55] L. Lessin,et al. The use of r‐HuEpo in the treatment of anaemia related to myelodysplasia (MDS) , 1995, British journal of haematology.
[56] M. Mittelman,et al. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. , 1992, Blood.
[57] J. Cook,et al. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. , 1992, The Journal of laboratory and clinical medicine.
[58] B. Bain,et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. , 1992, BMJ.
[59] S. Piantadosi,et al. Decreased erythropoietin response in patients with the anemia of cancer. , 1990, The New England journal of medicine.
[60] I. Cavill,et al. Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm. , 1990, British medical journal.
[61] I. Cavill,et al. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. , 1989, BMJ.
[62] M. Hochberg,et al. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. , 1988, Arthritis and rheumatism.
[63] J. Cook,et al. Serum ferritin: a possible model for the assessment of nutrient stores. , 1982, The American journal of clinical nutrition.
[64] Majid Ali,et al. FAILURE OF SERUM FERRITIN LEVELS TO PREDICT BONE-MARROW IRON CONTENT AFTER INTRAVENOUS IRON-DEXTRAN THERAPY , 1982, The Lancet.
[65] J. Winchester,et al. Hemosiderosis in hemodialysis patients. , 1981, JAMA.
[66] D. Malcolm,et al. Hemosiderosis in hemodialysis patients. An autopsy study of 50 cases. , 1980, JAMA.
[67] B. Lubin,et al. The influence of plasma bilirubin on zinc protoporphyrin measurement by a hematofluorimeter. , 1978, The Journal of laboratory and clinical medicine.
[68] K. Kalantar-Zadeh,et al. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients? , 2007, Nephrology news & issues.
[69] A. Kirschbaum,et al. The diagnostic plot , 2006, Medical oncology.
[70] Á. Remacha,et al. Clinical utility of the new Sysmex XE 2100 parameter - reticulocyte hemoglobin equivalent - in the diagnosis of anemia. , 2005, Haematologica.
[71] E. Hellström-Lindberg,et al. Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors. , 2004, Haematologica.
[72] M. Scott,et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. , 1998, Clinical chemistry.
[73] M. Kishino,et al. Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[74] S. Garrett,et al. Zinc protoporphyrin and iron-deficient erythropoiesis. , 1994, Acta haematologica.
[75] G Barosi,et al. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. , 1992, Blood.
[76] P. Pootrakul,et al. Intact transferrin receptors in human plasma and their relation to erythropoiesis. , 1990, Blood.
[77] Y. Niitsu,et al. Serum transferrin receptor as a new index of erythropoiesis. , 1987, Blood.